Ignite Creation Date:
2024-05-06 @ 12:53 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03874806
Status:
WITHDRAWN
Last Update Posted:
2019-07-15
First Post:
2019-03-08
Brief Title:
Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Study Overview
Official Title:
Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block a Comparison of Bolus Dosing and Continuous Infusion
Status:
WITHDRAWN
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Did not receive funding
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goals of this study are as follows
1 to confirm the safe dosing of ropivacaine for the erector spinae plane block
2 develop a pharmacokinetic profile of the erector spinae plane block which will help demonstrate how quickly and how closely toxic levels are reached when a routine dose of ropivacaine is given for this nerve block
3 assess numbness created by the erector spinae block when routine doses are administered
1 to confirm the safe dosing of ropivacaine for the erector spinae plane block
2 develop a pharmacokinetic profile of the erector spinae plane block which will help demonstrate how quickly and how closely toxic levels are reached when a routine dose of ropivacaine is given for this nerve block
3 assess numbness created by the erector spinae block when routine doses are administered
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None